GPCR vs MSFT: Which Stock is Better?
Side-by-side comparison of Structure Therapeutics Inc. American Depositary Shares and Microsoft Corporation in 2026
GPCR
Structure Therapeutics Inc. American Depositary Shares
$47.13
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | GPCR | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.09B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | GPCR |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze GPCR
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GPCR or MSFT a better investment?
Comparing GPCR and MSFT: Structure Therapeutics Inc. American Depositary Shares has a market cap of $1.09B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GPCR and MSFT?
GPCR (Structure Therapeutics Inc. American Depositary Shares) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GPCR or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GPCR or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for GPCR.
Which company is more profitable: GPCR or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for GPCR.
Which is the larger company: GPCR or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $1.09B for GPCR.
Should I buy GPCR or MSFT in 2026?
Both GPCR and MSFT have investment merit. GPCR trades at $47.13 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GPCR and MSFT stock?
Key differences: Market Cap ($1.09B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy GPCR or MSFT in 2026?
The choice between GPCR and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between GPCR and MSFT?
GPCR (Structure Therapeutics Inc. American Depositary Shares) has a market cap of $1.09B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.